Keywords: antidepressant, sales, boost, forest, 4th, qtr, new
Antidepressant sales boost Forest in 4th qtr
Article | 28 April 2003
New York, USA headquartered Forest Laboratories has posted a 42%increase in sales for its fiscal fourth quarter ended March 31, 2003, to $621.1 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
